Daniel Haller
Medical Oncology · Philadelphia, PANPI 1639112949
Payments from drug & device makers
Across 226 payments — averaging $1004.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$81K
- Merck$73K
- Taiho Oncology, Inc.$47K
- Exelixis Inc.$19K
- Lilly USA, LLC$6K
- Genentech USA, Inc.$127
What the payments were for
- Consulting fees$76,00533%
- Speaking & faculty fees$125,27655%
- Travel & lodging$23,28210%
- Food & beverage$2,3541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 120 | $81,210 |
| Merck | 31 | $72,792 |
| Taiho Oncology, Inc. | 50 | $47,346 |
| Exelixis Inc. | 20 | $19,318 |
| Lilly USA, LLC | 4 | $6,125 |
| Genentech USA, Inc. | 1 | $127 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$226,918 in reported general payments places this provider in the 65th percentile of 238 medical oncology providers in Pennsylvania.
Other medical oncology in Philadelphia
- Sukhmani PaddaPhiladelphia$25.6M
- Peter O DwyerPhiladelphia$18M
- Margaret von MehrenPhiladelphia$17.4M
- Kim Reiss BinderPhiladelphia$16.9M
- Carl JunePhiladelphia$13M
- Takami SatoPhiladelphia$11.5M
- Vivek NarayanPhiladelphia$10.6M
- Ubaldo Martinez-OutschoornPhiladelphia$10.5M
- Neil PalmisianoPhiladelphia$10.1M
- Anthony OlszanskiPhiladelphia$9.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.